LIQUIVISC 2.5 mg/g eye gel

Страна: Ирландия

Язык: английский

Источник: HPRA (Health Products Regulatory Authority)

Купи это сейчас

Активный ингредиент:

Carbomer

Доступна с:

Laboratoires Thea

код АТС:

S01XA; S01XA20

ИНН (Международная Имя):

Carbomer

дозировка:

2.5 milligram(s)/gram

Фармацевтическая форма:

Eye gel

Тип рецепта:

Product not subject to medical prescription

Терапевтические области:

Other ophthalmologicals; artificial tears and other indifferent preparations

Статус Авторизация:

Marketed

Дата Авторизация:

2003-08-22

тонкая брошюра

                                Turn over
IN THIS LEAFLET:
1. What LIQUIVISC is and
what it is used for
2. Before you use
LIQUIVISC
3. How to use LIQUIVISC
4. Possible side effects
5. How to store LIQUIVISC
6. Further information
1. WHAT LIQUIVISC IS AND
WHAT IT IS USED FOR
LIQUIVISC is a substitute
for tears and contains a
lubricant called Carbomer
974P.
It is an eye gel used for the
relief of the SYMPTOMS OF
DRY EYE (such as soreness,
burning, irritation or
dryness) caused by your
eyes not producing enough
Please tell your doctor or
pharmacist if you are taking
or have recently taken any
other medicines, including
medicines obtained without a
prescription.
If you have to use any
other eye medicine during
treatment with LIQUIVISC:
first use the other eye
medicine, wait 15 minutes,
then use LIQUIVISC.
PREGNANCY
AND BREAST-FEEDING
If you are pregnant or
breast-feeding, CONTACT your
DOCTOR for advice BEFORE you
start using LIQUIVISC.
He/she will decide if you can
use LIQUIVISC.
tears.
2. BEFORE YOU USE
LIQUIVISC
DO NOT USE LIQUIVISC:
• IF YOU ARE ALLERGIC
(hypersensitive) to
Carbomer or any of
the other ingredients
of LIQUIVISC listed
in Section 6, “What
LIQUIVISC contains”.
TAKE SPECIAL CARE WITH
LIQUIVISC:
• IF YOU WEAR SOFT CONTACT
LENSES: you must remove
them before using
LIQUIVISC eye gel. After
using LIQUIVISC, wait at
least 30 minutes before
putting your lenses back
DRIVING AND USING MACHINES
Your sight may become
blurred for a short time
just after using LIQUIVISC.
You should not drive or use
machines until your sight is
clear again.
LIQUIVISC CONTAINS
BENZALKONIUM CHLORIDE
This medicine contains
0,0015 mg benzalkonium
chloride in each drop which
is equivalent to 0,06 mg/g.
Benzalkonium chloride may
be absorbed by soft contact
lenses and may change the
colour of the contact lenses.
You should remove contact
lenses before using this
medicine and put them back
30 minutes afterwards.
in. See also in Section 2,
“LIQUIVISC CONTAINS
BENZALKONIUM CHLORIDE”.
• IF YOUR CONDITION
WORSENS OR HAS NOT
IMPROVED after having
started treatm
                                
                                Прочитать полный документ
                                
                            

Характеристики продукта

                                Health Products Regulatory Authority
06 May 2021
CRN00CCCG
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
LIQUIVISC 2.5 mg/g, eye gel
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Carbomer 974P 2.5 mg/g.
Excipient with known effect: benzalkonium chloride (0.06 mg/g).
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Eye gel
Slightly yellow and opalescent gel.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Symptomatic treatment of dry eye syndrome.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Ocular use.
ADULTS (INCLUDING THE ELDERLY):
Instil one drop of the gel into the inferior conjunctival cul-de-sac 1
to 4 times daily according to the degree of ocular trouble.
CHILDREN AND ADOLESCENTS AGED TO 18 YEARS:
The safety and efficacy of LIQUIVISC 2.5 mg/g eye gel in children and
adolescents at the posology recommended in adults has
been established by clinical experience, but no clinical trial data
are available.
After instillation, the bottle should be stored vertically with the
dropper downwards to facilitate the formation of drops when
next used.
Do not touch the eye with the dropper tip. Replace the cap after use.
4.3 CONTRAINDICATIONS
Hypersensitivity to any of the components of the product.
Health Products Regulatory Authority
06 May 2021
CRN00CCCG
Page 2 of 4
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
This medicine contains 0.0015 mg benzalkonium chloride in each drop.
Benzalkonium chloride is commonly used as a preservative in ophthalmic
products and has been reported rarely to cause
punctate keratopathy and/or ulcerative keratopathy.
Benzalkonium chloride has also been reported to cause eye irritation,
symptoms of dry eyes and may affect the tear film and
corneal surface. Should be used with caution in dry eye patients and
in patients where the cornea may be compromised.
Patients should be monitored in case of prolonged use.
Contact lenses:
Benzalkonium chloride may be absorbed by soft contact lenses and may
change the colour of the contact lenses. Patients

                                
                                Прочитать полный документ
                                
                            

Поиск оповещений, связанных с этим продуктом

Просмотр истории документов